Navigation Links
Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
Date:9/19/2008

WALTHAM, Mass., Sept. 19 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, today announced that Ron Zwanziger, Chairman, Chief Executive Officer and President, and Jon Russell, Vice President, Finance, are scheduled to attend the UBS Global Life Sciences Conference being held September 22-25, 2008 at the Grand Hyatt New York in New York City. The Company's presentation is scheduled for 1:00 p.m. on Monday, September 22, 2008 and will be made available to the public through an audio webcast accessible at http://www.ibb.ubs.com . A replay of the webcast will be available via the link above for 30 days. During its presentation, Inverness may discuss and answer questions concerning business and financial developments and trends. Responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com .

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
2. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
3. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
4. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
5. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
6. Inverness Medical Innovations Announces Second Quarter 2008 Results
7. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
8. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
9. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
10. Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
11. Inverness Medical Innovations to Participate at Morgan Stanley Global Healthcare Unplugged Conference on April 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  BioSpecifics Technologies Corp. (NASDAQ: ... class collagenase-based products marketed as XIAFLEX ® ... and XIAPEX ® in the EU, today ... double-blind Phase 2a study of CCH for the ... The results showed that all three doses of ...
(Date:8/21/2014)... 2014 DNA vaccine pioneer Immunomic ... development of JRC-LAMP-vax, an innovative and safe potential treatment ... studies began this month in Hawaii, moving the world ... The Japanese red cedar releases pollen that causes devastating ... Cedar pollen wreaks similar havoc in Colorado, New Mexico ...
(Date:8/21/2014)... the Institute for Molecular Medicine Finland (FIMM), University ... a novel "man and machine" decision support system ... was described in PLOS One scientific ... on computer vision algorithms similar to those used ... only the diagnostically most relevant areas. Tablet computers ...
(Date:8/21/2014)... research team including DESY scientists has observed tiny quantum ... reports in the journal Science that the ... the nanodroplets. It is the first time that the ... samples of what is known as superfluid helium, have ... best expectations," says Andrey Vilesov of the University of ...
Breaking Biology Technology:BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 3Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 4A novel 'man and machine' decision support system makes malaria diagnostics more effective 2Scientists observe quantum vortices in cold helium droplets 2
... Mo., Dec. 8 An investor group in Trinity,Biotech ... developer and manufacturer of,diagnostic products, has reconfigured the slate ... special meeting of the company,s shareholders,that the group is ... behalf of,the group, announced that Robert S. Winter, the ...
... 8 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... will participate in a panel,discussion at the 2008 RBC Capital ... Inflammation and Rheumatology", will take,place on Wednesday, December 10, 2008 ... New York City. , ...
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer and marketer ... received FDA clearance for the,marketing of the ATS 3f(R) Aortic ... improved valve holder accessory device. , ... While the ATS 3f Aortic Bioprosthesis ...
Cached Biology Technology:Investor Group Reconfigures Proposed Slate of Replacement Directors for Trinity Biotech 2ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis 2ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis 3
(Date:8/21/2014)... of scientists including researchers from the University of Georgia recently ... canolain the journal Science . Their discovery paves the ... widely in farming and industry. , Canola is grown ... winter crop is increasingly cultivated in Georgia. Canola oil used ... saturated fat and rich supply of omega-3 fatty acids, but ...
(Date:8/21/2014)... smog-producing toxins in past decade, GTA still violates ... that while the Greater Toronto Area (GTA) has ... to smog, the city continues to violate the ... can cause or aggravate health problems such as ... a set of complex photochemical reactions involving volatile ...
(Date:8/21/2014)... new study of American singles found that during ... highest orgasm rates. On average, men experience orgasm ... orientation making little difference. For women, however, orgasm ... orgasm 62.9 percent of the time during sex ... varies with women,s sexual orientation, with lesbian women ...
Breaking Biology News(10 mins):Canola genome sequence reveals evolutionary 'love triangle' 2Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 3Orgasm rates for single women less predictable than men's, vary by sexual orientation 4
... voracious predators and consume a wide range of prey, which ... proposed for why females eat males before or after mating. ... Ohio found, in a study published in the September issue ... be simpler than previously thought. Males are more likely to ...
... NEW YORK (September 10, 2008)A set of stripy legs in ... something to cheer about, say researchers from the Wildlife Conservation ... apparently has survived in the Democratic Republic of Congo,s Virunga ... increased poaching. "This is the first time this ...
... CORVALLIS, Ore. Contrary to 40 years of conventional wisdom, ... Nature suggests that old growth forests are usually ... from the atmosphere and mitigate climate change for centuries. ... protected by international treaties and have been considered of no ...
Cached Biology News:In spiders, size matters: Small males are more often meals 2Photo reveals rare okapi survived poaching onslaught 2Old growth forests are valuable carbon sinks 2Old growth forests are valuable carbon sinks 3
... ( Abpromise for all tested applications). ... to amino acids 14/26 of Mouse Green cones ... acids 18/30 of tiger red cones opsin 1 ... Entrez Gene ID: 5956 ...
Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
Request Info...
Myt 1 (N-17)...
Biology Products: